← Eichor
Study identifier: NCT06857916 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cycle and Stroke With Biofeedback for Power Symmetry

Condition: Stroke  ·  Sponsor: University of Utah

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

To determine changes in power symmetry, gait symmetry, and functional outcomes for participants' poststroke (Inpatient Rehabilitation Facility) after participating in an intervention using a recumbent cycle with power biofeedback (BFB). To determine how this intervention can impact gait asymmetry, a common disorder poststroke secondary to hemiparesis. Gait asymmetry is a difficult impairment to treat because it is difficult for both therapists and patients to perceive. Training with BFB allows for quantitative data about the power production or lack of that directly impacts safety in walking, increased energy expenditure, and decreased gait speed.

This description comes directly from the study's public registry record.

Talk to the study team

Heather A Hayes, PhD  ·  801-587-9249  ·  heather.hayes@hsc.utah.edu

Tamara Garff  ·  8015853122  ·  tamara.garff@hsc.utah.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University Health, Neilsen Rehabilitation HospitalSalt Lake City, Utah, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06857916